Earnings call transcript: Indoco Pharmaceuticals tops INR 500 crore in Q2 2026.
Earnings call transcript: Indoco Pharmaceuticals tops INR 500 crore in Q2 2026.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in